Cargando…
Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer
BACKGROUND: The incidence and mortality of early-onset colorectal cancer (EOCRC; < 50 years old) is increasing worldwide, with a high recurrence rate. The inherent heterogeneity of EOCRC makes its treatment challenging. Hence, to further understand the biology and reveal the molecular mechanisms...
Autores principales: | Yang, Jia, Zhao, Yuting, Yuan, Rongqiang, Wang, Yongtong, Wang, Shiyi, Chang, Zhiqiang, Zhao, Wenyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658991/ https://www.ncbi.nlm.nih.gov/pubmed/37986009 http://dx.doi.org/10.1186/s40001-023-01491-y |
Ejemplares similares
-
Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma
por: Peng, Fuduan, et al.
Publicado: (2017) -
Identification of Prognostic Dosage-Sensitive Genes in Colorectal Cancer Based on Multi-Omics
por: Chang, Zhiqiang, et al.
Publicado: (2020) -
Individualized predictive signatures for 5‐fluorouracil‐based chemotherapy in right‐ and left‐sided colon cancer
por: Song, Kai, et al.
Publicado: (2018) -
A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources
por: Zhao, Wenyuan, et al.
Publicado: (2016) -
Identifying prognostic signatures in the microenvironment of prostate cancer
por: Lu, Guoliang, et al.
Publicado: (2021)